J. P. Smith

1.2k total citations
36 papers, 936 citations indexed

About

J. P. Smith is a scholar working on Rheumatology, Pulmonary and Respiratory Medicine and Epidemiology. According to data from OpenAlex, J. P. Smith has authored 36 papers receiving a total of 936 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Rheumatology, 6 papers in Pulmonary and Respiratory Medicine and 6 papers in Epidemiology. Recurrent topics in J. P. Smith's work include Rheumatoid Arthritis Research and Therapies (6 papers), Microbial infections and disease research (3 papers) and Metabolism and Genetic Disorders (2 papers). J. P. Smith is often cited by papers focused on Rheumatoid Arthritis Research and Therapies (6 papers), Microbial infections and disease research (3 papers) and Metabolism and Genetic Disorders (2 papers). J. P. Smith collaborates with scholars based in United Kingdom, United States and Greece. J. P. Smith's co-authors include L. Golberg, L. Martin, George D. Kitas, Peter Nightingale, Karen Douglas, Jeremy C. Smith, V. F. Panoulas, Antonios Stavropoulos‐Kalinoglou, George S. Metsios and P. O. Yates and has published in prestigious journals such as Nature, American Journal of Respiratory and Critical Care Medicine and Radiology.

In The Last Decade

J. P. Smith

35 papers receiving 796 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
J. P. Smith United Kingdom 19 245 167 129 108 105 36 936
R A Crockson United Kingdom 17 413 1.7× 232 1.4× 212 1.6× 120 1.1× 134 1.3× 24 1.2k
A. J. Bellingham United Kingdom 25 79 0.3× 597 3.6× 290 2.2× 138 1.3× 168 1.6× 79 1.8k
N Raknerud Norway 19 100 0.4× 133 0.8× 175 1.4× 67 0.6× 202 1.9× 43 1.6k
L. W. Powell Australia 20 75 0.3× 386 2.3× 316 2.4× 88 0.8× 280 2.7× 58 2.3k
M. Seigneur France 18 130 0.5× 186 1.1× 108 0.8× 101 0.9× 174 1.7× 31 891
H Popper United States 16 107 0.4× 39 0.2× 124 1.0× 69 0.6× 220 2.1× 55 1.5k
Maarten T.M. Raijmakers Netherlands 20 175 0.7× 53 0.3× 246 1.9× 125 1.2× 86 0.8× 51 1.5k
Élbio Antônio D’Amico Brazil 16 106 0.4× 113 0.7× 96 0.7× 70 0.6× 235 2.2× 57 968
H. C. Seftel South Africa 21 71 0.3× 444 2.7× 143 1.1× 58 0.5× 274 2.6× 52 1.4k
A. Killander Sweden 20 161 0.7× 662 4.0× 192 1.5× 92 0.9× 60 0.6× 75 1.2k

Countries citing papers authored by J. P. Smith

Since Specialization
Citations

This map shows the geographic impact of J. P. Smith's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J. P. Smith with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J. P. Smith more than expected).

Fields of papers citing papers by J. P. Smith

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J. P. Smith. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J. P. Smith. The network helps show where J. P. Smith may publish in the future.

Co-authorship network of co-authors of J. P. Smith

This figure shows the co-authorship network connecting the top 25 collaborators of J. P. Smith. A scholar is included among the top collaborators of J. P. Smith based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J. P. Smith. J. P. Smith is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Diab, Nabil, Elena Kum, Waleed Hassan, et al.. (2025). Mepolizumab for the Treatment of Refractory Chronic Cough With Eosinophilic Airways Disease (MUCOSA): A Randomized, Double-blind, Placebo-controlled Trial. American Journal of Respiratory and Critical Care Medicine. 211(Supplement_1). A2102–A2102. 1 indexed citations
2.
Dimitroulas, Theodoros, Aamer Sandoo, Jet Veldhuijzen Zanten, et al.. (2013). Predictors of asymmetric dimethylarginine levels in patients with rheumatoid arthritis: the role of insulin resistance. Scandinavian Journal of Rheumatology. 42(3). 176–181. 15 indexed citations
3.
Sandoo, Aamer, Theodoros Dimitroulas, Jet Veldhuijzen Zanten, et al.. (2012). Lack of association between asymmetric dimethylarginine and in vivo microvascular and macrovascular endothelial function in patients with rheumatoid arthritis.. PubMed. 30(3). 388–96. 38 indexed citations
4.
Stavropoulos‐Kalinoglou, Antonios, George S. Metsios, J. P. Smith, et al.. (2009). What predicts obesity in patients with rheumatoid arthritis? An investigation of the interactions between lifestyle and inflammation. International Journal of Obesity. 34(2). 295–301. 37 indexed citations
5.
Toms, Tracey E., V. F. Panoulas, Karen Douglas, et al.. (2009). Statin use in rheumatoid arthritis in relation to actual cardiovascular risk: evidence for substantial undertreatment of lipid-associated cardiovascular risk?. Annals of the Rheumatic Diseases. 69(4). 683–688. 104 indexed citations
6.
Panoulas, Vasileios, Karen Douglas, J. P. Smith, et al.. (2008). Transforming growth factor- 1 869T/C, but not interleukin-6 -174G/C, polymorphism associates with hypertension in rheumatoid arthritis. Lara D. Veeken. 48(2). 113–118. 40 indexed citations
7.
Panoulas, V. F., Spyros N. Nikas, J. P. Smith, et al.. (2008). Lymphotoxin 252A>G polymorphism is common and associates with myocardial infarction in patients with rheumatoid arthritis. Annals of the Rheumatic Diseases. 67(11). 1550–1556. 48 indexed citations
8.
Smith, J. P., et al.. (1990). Diabetes Mellitus and Lipoatrophy. Southern Medical Journal. 83(5). 573–576. 4 indexed citations
9.
Harvey‐White, Judith, et al.. (1983). Reference serum pepsinogen concentrations in dairy cattle. American Journal of Veterinary Research. 44(1). 115–117. 10 indexed citations
10.
Campbell, Sammy C. & J. P. Smith. (1982). An evaluation of reactivity to Coccidioides immitis skin tests in subjects with diabetes mellitus. Mycopathologia. 80(3). 133–136. 4 indexed citations
11.
Smith, J. P., et al.. (1963). Malignant Lymphoma of the Testis. BMJ. 2(5362). 891–894. 56 indexed citations
12.
Golberg, L. & J. P. Smith. (1960). Vitamin A and E deficiencies in relation to iron overloading in the rat. The Journal of Pathology and Bacteriology. 80(1). 173–180. 20 indexed citations
13.
Golberg, L. & J. P. Smith. (1958). Changes associated with the accumulation of excessive amounts of iron in certain organs of the rat.. PubMed. 39(1). 59–73. 35 indexed citations
14.
Golberg, L., J. P. Smith, & L. Martin. (1957). The effects of intensive and prolonged administration of iron parenterally in animals.. PubMed. 38(3). 297–311. 41 indexed citations
15.
Smith, Jeremy C., J. E. Kench, & J. P. Smith. (1957). Chemical and Histological Post-mortem Studies on a Workman Exposed for Many Years to Cadmium Oxide Fume. Occupational and Environmental Medicine. 14(4). 246–249. 17 indexed citations
16.
Smith, J. P.. (1956). Hyaline arteriolosclerosis in spleen, pancreas and other viscera. The Journal of Pathology and Bacteriology. 72(2). 643–656. 16 indexed citations
17.
Smith, J. P.. (1955). Hyaline arteriolosclerosis in the kidney. The Journal of Pathology and Bacteriology. 69(1). 147–168. 85 indexed citations
18.
Golberg, L. & J. P. Smith. (1954). The influence of aureomycin on the response of the rabbit to cholesterol feeding. The Journal of Pathology and Bacteriology. 68(2). 475–493. 3 indexed citations
19.
Langley, F. A., J. P. Smith, & A. S. Woodcock. (1953). Debatable Uterine Tumours. Acta Obstetricia Et Gynecologica Scandinavica. 32(2). 143–169. 16 indexed citations
20.
Smith, J. P.. (1952). The pathology of ferrous sulphate poisoning. The Journal of Pathology and Bacteriology. 64(3). 467–472. 28 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026